This Comment aims to examine the true extent of buprenorphine diversion and, thus, the public health impact that its reclassification as a Schedule II controlled substance would likely have. Part I details the increasing dependence on and abuse of opioids among vulnerable populations in the...

The United States Patent and Trademark Office is tasked with reading and reviewing patent applications to determine those applications which qualify for patent protection. Each application is reviewed by a specific patent examiner who should apply the standards of patentability in an even, fair,...

This article departs from the dogma that Funk Brothers delineates the limits of patentable subject matter and gives several rationales for why Funk Brothers is, in actuality, a case that outlines an obviousness standard. As an initial matter, one only needs to look to the historical background...

This article explores the use of artificial intelligence to help define the current test for copyright infringement. Currently, the test for copyright infringement requires the jury or a judge to determine whether the parties’ works are “substantially similar” to each other from the...

A recent study by professors found that women represent only one-third of the top pharmaceutical patent litigators and one-quarter of lawyers who help inventors obtain these valuable pharmaceutical patents. This lack of representation in the pharmaceutical patent field is surprising because...

Bioprinting is an additive manufacturing process used to create architectures that mimic natural living tissues in form and function. It involves the deposition of bioink, which can include a mixture of living cells, nutrients, and extracellular matrix. The bioink is then deposited onto a...

This Viewpoint discusses 3 bills introduced recently in Congress that focus on patent eligibility, fraud, and quality and that have major implications for clinical medicine and pharmaceutical development.Link to full text at JAMA: https://jamanetwork.com/journals/jama/fullarticle/2800700

This paper evaluates the potential impact of the Supreme Court’s upcoming decision on antibody patents and patent law’s enablement requirement on patient access to new drugs.This article was published in JAMA at https://jamanetwork.com/journals/jama/fullarticle/2803076

Less than a handful of casebooks are truly open source, in the sense of being fully modifiable. Patent Law: An Open-Source Casebook is the first patent law casebook that provides adopting professors, students, and others the ability to fully modify its contents. This file comprises the casebook...